Join CBSET at the MedTech Strategist Investment & Partnering Virtual Summit, November 17-19. Bringing together avast global medtech network, MedTech Strategist has structured a virtual event that will enable the global community to engage, network, and partner with the top players in the device industry. Please contact us to schedule an e-meeting around the MedTech […]
Join CBSET’s partner CILcare at the 3rd annual Neuropsychiatric Drug Development Summit November 10-12, 2020, 2020. Returning as an interactive, virtual meeting, this definitive industry meeting is focused on helping companies develop the next generation of more clinically effective therapeutics. With an emphasis on depressive disorders, schizophrenia, addiction and PTSD, this timely meeting provides a […]
Join CBSET’s partner CILcare at the 3rd annual Neuropsychiatric Drug Development Summit November 10-12, 2020, 2020. Returning as an interactive, virtual meeting, this definitive industry meeting is focused on helping companies develop the next generation of more clinically effective therapeutics. With an emphasis on depressive disorders, schizophrenia, addiction and PTSD, this timely meeting provides a […]
CBSET offers Scanning Electron Microscopy (SEM) services that complement our other services, including in-life studies, pathology services, and mechanical testing. We combine our advanced SEM techniques and experience in pathology and regulatory review to meet the critical needs of our clients, including assessment of tissue and material characterization after in vivo device treatments, investigation of device integrity […]
Long-term stimulation of sympathetic activity has been linked to the pathophysiology of chronic diseases such as systemic hypertension, metabolic syndrome, sleep apnea, heart failure, liver cirrhosis and rheumatoid arthritis. Thus, reduction of sympathetic nerve activity via local nerve ablation has emerged as an attractive therapy for hypertension and other chronic diseases. As a result, the […]
In Europe and North America, an estimated 27 million individuals are affected with peripheral artery disease (PAD), which is caused by the accumulation of plaque in peripheral arteries (commonly the pelvis or leg) reducing blood flow. Left untreated, PAD can lead to severe pain, immobility, non-healing wounds and eventually limb amputation. With risk factors such […]
Abraham Tzafriri , Benny Muraj , Fernando Gacia-Polite , Antonio-Gabino Salazar-Martin , Peter Markham , Anna-Maria Spognardi , Brett Zani , Mazen Albaghdadi , Steve Alston , and Elazer Edelman. “Drug-Coated Balloon Contact Pressure Predicts Endoluminal Coating Distribution.” Background: Paclitaxel-coated balloons (PCBs) control iliofemoral atherosclerotic lesions, yet restenosis rates remain hight without calss effect. We […]
September 30, 2020—CBSET Inc., a not-for-profit translational research institute, announced the publication of a preclinical study, “Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients,” by Abraham R. Tzafriri, PhD, et al, online ahead of print in the Journal of Biomaterials.
“These preclinical studies transform our understanding of how drug coated balloons deliver drug to the artery and why there is no class effect, while also providing tools for understanding the role of tissue stiffening with disease. The combination of mechanistic insight with predictive modeling can help accelerate development of new technologies such as those including […]
LEXINGTON, MA — September 23, 2020 — CBSET Inc., a not-for-profit translational research institute, announced today that the company and its partner, CILcare, a leading CRO specializing in hearing disorders, have been nominated to receive a prestigious Prix Galien MedStartUp award for their collaboration in fighting hearing loss; the collaborators are nominated in the category […]